CEO Pernilla Sandwall attends the Nordic Health Summit Japan
The conference will take place in Tokyo on April 25, 2023 . Keynote speakers are representatives from both Eisai, Solasia, AstraZeneca, and NovoNordisk.Pernilla will participate digitally and conduct one-to-one meetings with potential Japanese partners and present the company and the drug candidate Foxy-5. Foxy-5 aims to inhibit the ability of tumour cells to spread in the body and is in phase 2 clinical development. Pernilla will talk about the interesting ad hoc‑observations made in connection with the ongoing study. The study is conducted in patients